ibopamine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| dopaminergic agents dopamine derivatives used as cardiac stimulant/antihypertensives/diuretics | 1405 | 66195-31-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 0.30 | g | O |
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | C01CA16 | CARDIOVASCULAR SYSTEM CARDIAC THERAPY CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES Adrenergic and dopaminergic agents |
| ATC | S01FB03 | SENSORY ORGANS OPHTHALMOLOGICALS MYDRIATICS AND CYCLOPLEGICS Sympathomimetics excl. antiglaucoma preparations |
| MeSH PA | D002316 | Cardiotonic Agents |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D004232 | Diuretics |
| MeSH PA | D015259 | Dopamine Agents |
| MeSH PA | D018491 | Dopamine Agonists |
| MeSH PA | D009184 | Mydriatics |
| MeSH PA | D045283 | Natriuretic Agents |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D020011 | Protective Agents |
| MeSH PA | D014665 | Vasodilator Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Heart failure | indication | 84114007 | DOID:6000 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.34 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D04488 | KEGG_DRUG |
| C0123043 | UMLSCUI |
| CHEBI:135306 | CHEBI |
| CHEBI:10554 | CHEBI |
| CHEMBL307739 | ChEMBL_ID |
| DB13316 | DRUGBANK_ID |
| C023487 | MESH_SUPPLEMENTAL_RECORD_UI |
| 68555 | PUBCHEM_CID |
| 4806 | INN_ID |
| 75011-65-3 | SECONDARY_CAS_RN |
| 8ZCA2I2L11 | UNII |
| DB13917 | DRUGBANK_ID |
| 284157 | RXNORM |
| 009056 | NDDF |
| 009057 | NDDF |
| 717169003 | SNOMEDCT_US |
| 717171003 | SNOMEDCT_US |
| C0878280 | UMLSCUI |
| 4382 | PUBCHEM_CID |
| D003846 | MESH_DESCRIPTOR_UI |
Pharmaceutical products:
None